#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4.
1-1	0-2	4.	_	_	_	_

#Text=Discussion
2-1	3-13	Discussion	abstract	new	_	_

#Text=Our study , conducted on a limited , though well characterized , number of young , healthy volunteers , aimed at comparing the autonomic response to cognitive and sensory tests to the best of our knowledge , and tried to fill in a significant gap in the existing literature .
3-1	14-17	Our	person|event[3]	acc|new[3]	ana|ana	3-35|3-35
3-2	18-23	study	event[3]	new[3]	_	_
3-3	24-25	,	_	_	_	_
3-4	26-35	conducted	_	_	_	_
3-5	36-38	on	_	_	_	_
3-6	39-40	a	_	_	_	_
3-7	41-48	limited	_	_	_	_
3-8	49-50	,	_	_	_	_
3-9	51-57	though	_	_	_	_
3-10	58-62	well	_	_	_	_
3-11	63-76	characterized	_	_	_	_
3-12	77-78	,	_	_	_	_
3-13	79-85	number	quantity[4]	new[4]	_	_
3-14	86-88	of	quantity[4]	new[4]	_	_
3-15	89-94	young	quantity[4]|person[5]	new[4]|new[5]	coref	20-58[165_5]
3-16	95-96	,	quantity[4]|person[5]	new[4]|new[5]	_	_
3-17	97-104	healthy	quantity[4]|person[5]	new[4]|new[5]	_	_
3-18	105-115	volunteers	quantity[4]|person[5]	new[4]|new[5]	_	_
3-19	116-117	,	_	_	_	_
3-20	118-123	aimed	_	_	_	_
3-21	124-126	at	_	_	_	_
3-22	127-136	comparing	_	_	_	_
3-23	137-140	the	abstract[6]	new[6]	coref	4-19[16_6]
3-24	141-150	autonomic	abstract[6]	new[6]	_	_
3-25	151-159	response	abstract[6]	new[6]	_	_
3-26	160-162	to	abstract[6]	new[6]	_	_
3-27	163-172	cognitive	abstract[6]|abstract[7]	new[6]|new[7]	coref	13-26[108_7]
3-28	173-176	and	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-29	177-184	sensory	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-30	185-190	tests	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-31	191-193	to	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-32	194-197	the	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-33	198-202	best	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-34	203-205	of	_	_	_	_
3-35	206-209	our	person|abstract[9]	giv|new[9]	ana|ana	5-18|5-18
3-36	210-219	knowledge	abstract[9]	new[9]	_	_
3-37	220-221	,	_	_	_	_
3-38	222-225	and	_	_	_	_
3-39	226-231	tried	_	_	_	_
3-40	232-234	to	_	_	_	_
3-41	235-239	fill	_	_	_	_
3-42	240-242	in	_	_	_	_
3-43	243-244	a	time[10]	new[10]	coref	7-15[39_10]
3-44	245-256	significant	time[10]	new[10]	_	_
3-45	257-260	gap	time[10]	new[10]	_	_
3-46	261-263	in	time[10]	new[10]	_	_
3-47	264-267	the	time[10]|abstract[11]	new[10]|new[11]	_	_
3-48	268-276	existing	time[10]|abstract[11]	new[10]|new[11]	_	_
3-49	277-287	literature	time[10]|abstract[11]	new[10]|new[11]	_	_
3-50	288-289	.	_	_	_	_

#Text=With respect to the baseline , the presentation of the six different olfactory stimuli was seen to elicit a significant response in terms of activation of the sympathetic branch of the ANS .
4-1	290-294	With	_	_	_	_
4-2	295-302	respect	abstract[12]	new[12]	coref	8-7[44_12]
4-3	303-305	to	abstract[12]	new[12]	_	_
4-4	306-309	the	abstract[12]|abstract[13]	new[12]|new[13]	_	_
4-5	310-318	baseline	abstract[12]|abstract[13]	new[12]|new[13]	_	_
4-6	319-320	,	_	_	_	_
4-7	321-324	the	abstract[14]	new[14]	_	_
4-8	325-337	presentation	abstract[14]	new[14]	_	_
4-9	338-340	of	_	_	_	_
4-10	341-344	the	abstract[15]	new[15]	_	_
4-11	345-348	six	abstract[15]	new[15]	_	_
4-12	349-358	different	abstract[15]	new[15]	_	_
4-13	359-368	olfactory	abstract[15]	new[15]	_	_
4-14	369-376	stimuli	abstract[15]	new[15]	_	_
4-15	377-380	was	_	_	_	_
4-16	381-385	seen	_	_	_	_
4-17	386-388	to	_	_	_	_
4-18	389-395	elicit	_	_	_	_
4-19	396-397	a	abstract[16]	giv[16]	coref	11-16[92_16]
4-20	398-409	significant	abstract[16]	giv[16]	_	_
4-21	410-418	response	abstract[16]	giv[16]	_	_
4-22	419-421	in	abstract[16]	giv[16]	_	_
4-23	422-427	terms	abstract[16]	giv[16]	_	_
4-24	428-430	of	abstract[16]	giv[16]	_	_
4-25	431-441	activation	abstract[16]|abstract[17]	giv[16]|new[17]	coref	10-42[86_17]
4-26	442-444	of	abstract[16]|abstract[17]	giv[16]|new[17]	_	_
4-27	445-448	the	abstract[16]|abstract[17]|abstract[18]	giv[16]|new[17]|new[18]	_	_
4-28	449-460	sympathetic	abstract[16]|abstract[17]|abstract[18]	giv[16]|new[17]|new[18]	_	_
4-29	461-467	branch	abstract[16]|abstract[17]|abstract[18]	giv[16]|new[17]|new[18]	_	_
4-30	468-470	of	abstract[16]|abstract[17]|abstract[18]	giv[16]|new[17]|new[18]	_	_
4-31	471-474	the	abstract[16]|abstract[17]|abstract[18]|place[19]	giv[16]|new[17]|new[18]|new[19]	coref	8-15[0_19]
4-32	475-478	ANS	abstract[16]|abstract[17]|abstract[18]|place[19]	giv[16]|new[17]|new[18]|new[19]	_	_
4-33	479-480	.	_	_	_	_

#Text=Having reported that the olfactory compounds used included odors normally judged as both pleasant and unpleasant , our findings are somewhat similar to the retrievals of Bensafi et al. , limited to unpleasant odors .
5-1	481-487	Having	_	_	_	_
5-2	488-496	reported	_	_	_	_
5-3	497-501	that	_	_	_	_
5-4	502-505	the	object[20]	new[20]	_	_
5-5	506-515	olfactory	object[20]	new[20]	_	_
5-6	516-525	compounds	object[20]	new[20]	_	_
5-7	526-530	used	_	_	_	_
5-8	531-539	included	_	_	_	_
5-9	540-545	odors	abstract	new	coref	5-33[26_0]
5-10	546-554	normally	_	_	_	_
5-11	555-561	judged	_	_	_	_
5-12	562-564	as	_	_	_	_
5-13	565-569	both	_	_	_	_
5-14	570-578	pleasant	_	_	_	_
5-15	579-582	and	_	_	_	_
5-16	583-593	unpleasant	_	_	_	_
5-17	594-595	,	_	_	_	_
5-18	596-599	our	person|abstract[23]	giv|new[23]	ana|coref|ana|coref	6-4|9-30[70_23]|6-4|9-30[70_23]
5-19	600-608	findings	abstract[23]	new[23]	_	_
5-20	609-612	are	_	_	_	_
5-21	613-621	somewhat	_	_	_	_
5-22	622-629	similar	_	_	_	_
5-23	630-632	to	_	_	_	_
5-24	633-636	the	abstract[24]	new[24]	_	_
5-25	637-647	retrievals	abstract[24]	new[24]	_	_
5-26	648-650	of	abstract[24]	new[24]	_	_
5-27	651-658	Bensafi	abstract[24]|person	new[24]|new	_	_
5-28	659-661	et	abstract[24]	new[24]	_	_
5-29	662-665	al.	abstract[24]	new[24]	_	_
5-30	666-667	,	abstract[24]	new[24]	_	_
5-31	668-675	limited	abstract[24]	new[24]	_	_
5-32	676-678	to	_	_	_	_
5-33	679-689	unpleasant	abstract[26]	giv[26]	coref	6-23[0_26]
5-34	690-695	odors	abstract[26]	giv[26]	_	_
5-35	696-697	.	_	_	_	_

#Text=In addition , we also failed to find significant correlations between autonomic parameters and odor pleasantness , confirming that pleasant versus unpleasant odors do not cause significantly different autonomic responses in healthy subjects .
6-1	698-700	In	_	_	_	_
6-2	701-709	addition	_	_	_	_
6-3	710-711	,	_	_	_	_
6-4	712-714	we	person	giv	ana	9-30
6-5	715-719	also	_	_	_	_
6-6	720-726	failed	_	_	_	_
6-7	727-729	to	_	_	_	_
6-8	730-734	find	_	_	_	_
6-9	735-746	significant	abstract[28]	new[28]	coref	23-12[190_28]
6-10	747-759	correlations	abstract[28]	new[28]	_	_
6-11	760-767	between	abstract[28]	new[28]	_	_
6-12	768-777	autonomic	abstract[28]|abstract[29]	new[28]|new[29]	coref	23-24[194_29]
6-13	778-788	parameters	abstract[28]|abstract[29]	new[28]|new[29]	_	_
6-14	789-792	and	abstract[28]	new[28]	_	_
6-15	793-797	odor	abstract[28]|abstract|abstract[31]	new[28]|new|new[31]	_	_
6-16	798-810	pleasantness	abstract[28]|abstract[31]	new[28]|new[31]	_	_
6-17	811-812	,	_	_	_	_
6-18	813-823	confirming	_	_	_	_
6-19	824-828	that	_	_	_	_
6-20	829-837	pleasant	_	_	_	_
6-21	838-844	versus	_	_	_	_
6-22	845-855	unpleasant	_	_	_	_
6-23	856-861	odors	abstract	giv	_	_
6-24	862-864	do	_	_	_	_
6-25	865-868	not	_	_	_	_
6-26	869-874	cause	_	_	_	_
6-27	875-888	significantly	abstract[33]	new[33]	coref	10-4[73_33]
6-28	889-898	different	abstract[33]	new[33]	_	_
6-29	899-908	autonomic	abstract[33]	new[33]	_	_
6-30	909-918	responses	abstract[33]	new[33]	_	_
6-31	919-921	in	abstract[33]	new[33]	_	_
6-32	922-929	healthy	abstract[33]|abstract[34]	new[33]|new[34]	coref	13-22[106_34]
6-33	930-938	subjects	abstract[33]|abstract[34]	new[33]|new[34]	_	_
6-34	939-940	.	_	_	_	_

#Text=After the olfactory stimulation , the TSST further increased the SNS activity , at the same time highlighting a somewhat parasympathetic withdrawal , as demonstrated by the simultaneous decrease of both SDNN and pNN50 .
7-1	941-946	After	_	_	_	_
7-2	947-950	the	abstract[35]	new[35]	coref	10-7[74_35]
7-3	951-960	olfactory	abstract[35]	new[35]	_	_
7-4	961-972	stimulation	abstract[35]	new[35]	_	_
7-5	973-974	,	_	_	_	_
7-6	975-978	the	abstract[36]	new[36]	coref	8-9[45_36]
7-7	979-983	TSST	abstract[36]	new[36]	_	_
7-8	984-991	further	_	_	_	_
7-9	992-1001	increased	_	_	_	_
7-10	1002-1005	the	abstract[38]	new[38]	coref	14-29[123_38]
7-11	1006-1009	SNS	abstract|abstract[38]	new|new[38]	coref	10-43
7-12	1010-1018	activity	abstract[38]	new[38]	_	_
7-13	1019-1020	,	_	_	_	_
7-14	1021-1023	at	_	_	_	_
7-15	1024-1027	the	time[39]	giv[39]	_	_
7-16	1028-1032	same	time[39]	giv[39]	_	_
7-17	1033-1037	time	time[39]	giv[39]	_	_
7-18	1038-1050	highlighting	_	_	_	_
7-19	1051-1052	a	abstract[40]	new[40]	coref	14-16[117_40]
7-20	1053-1061	somewhat	abstract[40]	new[40]	_	_
7-21	1062-1077	parasympathetic	abstract[40]	new[40]	_	_
7-22	1078-1088	withdrawal	abstract[40]	new[40]	_	_
7-23	1089-1090	,	_	_	_	_
7-24	1091-1093	as	_	_	_	_
7-25	1094-1106	demonstrated	_	_	_	_
7-26	1107-1109	by	_	_	_	_
7-27	1110-1113	the	abstract[41]	new[41]	_	_
7-28	1114-1126	simultaneous	abstract[41]	new[41]	_	_
7-29	1127-1135	decrease	abstract[41]	new[41]	_	_
7-30	1136-1138	of	abstract[41]	new[41]	_	_
7-31	1139-1143	both	abstract[41]|abstract[42]	new[41]|new[42]	_	_
7-32	1144-1148	SDNN	abstract[41]|abstract[42]	new[41]|new[42]	_	_
7-33	1149-1152	and	abstract[41]	new[41]	_	_
7-34	1153-1158	pNN50	abstract[41]|quantity	new[41]|new	_	_
7-35	1159-1160	.	_	_	_	_

#Text=Despite not being extensively studied with respect to the TSST , this kind of ANS behavior is consistent with the results by Boesch et al. , which , with a slightly different protocol , found an increase in HR together with a contextual decrease of HRV features during the administration of the TSST for groups ( TSST-G ) .
8-1	1161-1168	Despite	_	_	_	_
8-2	1169-1172	not	_	_	_	_
8-3	1173-1178	being	_	_	_	_
8-4	1179-1190	extensively	_	_	_	_
8-5	1191-1198	studied	_	_	_	_
8-6	1199-1203	with	_	_	_	_
8-7	1204-1211	respect	abstract[44]	giv[44]	_	_
8-8	1212-1214	to	abstract[44]	giv[44]	_	_
8-9	1215-1218	the	abstract[44]|abstract[45]	giv[44]|giv[45]	coref	8-52[57_45]
8-10	1219-1223	TSST	abstract[44]|abstract[45]	giv[44]|giv[45]	_	_
8-11	1224-1225	,	_	_	_	_
8-12	1226-1230	this	_	_	_	_
8-13	1231-1235	kind	abstract[47]	new[47]	coref	16-23[136_47]
8-14	1236-1238	of	abstract[47]	new[47]	_	_
8-15	1239-1242	ANS	place|abstract[47]	giv|new[47]	coref	10-4
8-16	1243-1251	behavior	abstract[47]	new[47]	_	_
8-17	1252-1254	is	_	_	_	_
8-18	1255-1265	consistent	_	_	_	_
8-19	1266-1270	with	_	_	_	_
8-20	1271-1274	the	abstract[48]	new[48]	coref	9-1[60_48]
8-21	1275-1282	results	abstract[48]	new[48]	_	_
8-22	1283-1285	by	abstract[48]	new[48]	_	_
8-23	1286-1292	Boesch	abstract[48]|person	new[48]|new	_	_
8-24	1293-1295	et	abstract[48]	new[48]	_	_
8-25	1296-1299	al.	abstract[48]	new[48]	_	_
8-26	1300-1301	,	_	_	_	_
8-27	1302-1307	which	_	_	_	_
8-28	1308-1309	,	_	_	_	_
8-29	1310-1314	with	_	_	_	_
8-30	1315-1316	a	abstract[50]	new[50]	coref	10-11[76_50]
8-31	1317-1325	slightly	abstract[50]	new[50]	_	_
8-32	1326-1335	different	abstract[50]	new[50]	_	_
8-33	1336-1344	protocol	abstract[50]	new[50]	_	_
8-34	1345-1346	,	_	_	_	_
8-35	1347-1352	found	_	_	_	_
8-36	1353-1355	an	abstract[51]	new[51]	_	_
8-37	1356-1364	increase	abstract[51]	new[51]	_	_
8-38	1365-1367	in	abstract[51]	new[51]	_	_
8-39	1368-1370	HR	abstract[51]|time	new[51]|new	coref	9-6
8-40	1371-1379	together	_	_	_	_
8-41	1380-1384	with	_	_	_	_
8-42	1385-1386	a	event[53]	new[53]	_	_
8-43	1387-1397	contextual	event[53]	new[53]	_	_
8-44	1398-1406	decrease	event[53]	new[53]	_	_
8-45	1407-1409	of	event[53]	new[53]	_	_
8-46	1410-1413	HRV	event[53]|abstract|abstract[55]	new[53]|new|new[55]	coref|coref|coref|coref	9-9|27-12[210_55]|9-9|27-12[210_55]
8-47	1414-1422	features	event[53]|abstract[55]	new[53]|new[55]	_	_
8-48	1423-1429	during	event[53]|abstract[55]	new[53]|new[55]	_	_
8-49	1430-1433	the	event[53]|abstract[55]|event[56]	new[53]|new[55]|new[56]	_	_
8-50	1434-1448	administration	event[53]|abstract[55]|event[56]	new[53]|new[55]|new[56]	_	_
8-51	1449-1451	of	event[53]|abstract[55]|event[56]	new[53]|new[55]|new[56]	_	_
8-52	1452-1455	the	event[53]|abstract[55]|event[56]|abstract[57]	new[53]|new[55]|new[56]|giv[57]	coref	9-12[0_57]
8-53	1456-1460	TSST	event[53]|abstract[55]|event[56]|abstract[57]	new[53]|new[55]|new[56]|giv[57]	_	_
8-54	1461-1464	for	event[53]|abstract[55]|event[56]|abstract[57]	new[53]|new[55]|new[56]|giv[57]	_	_
8-55	1465-1471	groups	event[53]|abstract[55]|event[56]|abstract[57]|person	new[53]|new[55]|new[56]|giv[57]|new	_	_
8-56	1472-1473	(	_	_	_	_
8-57	1474-1480	TSST-G	abstract	new	_	_
8-58	1481-1482	)	_	_	_	_
8-59	1483-1484	.	_	_	_	_

#Text=Similar results in terms of HR augmentation and HRV reduction under TSST stress were also found in several other protocols ( see ) , strengthening the scientific value of our findings .
9-1	1485-1492	Similar	abstract[60]	giv[60]	coref	27-3[208_60]
9-2	1493-1500	results	abstract[60]	giv[60]	_	_
9-3	1501-1503	in	abstract[60]	giv[60]	_	_
9-4	1504-1509	terms	abstract[60]	giv[60]	_	_
9-5	1510-1512	of	abstract[60]	giv[60]	_	_
9-6	1513-1515	HR	abstract[60]|time|abstract[62]	giv[60]|giv|new[62]	_	_
9-7	1516-1528	augmentation	abstract[60]|abstract[62]	giv[60]|new[62]	_	_
9-8	1529-1532	and	abstract[60]	giv[60]	_	_
9-9	1533-1536	HRV	abstract[60]|abstract|abstract[64]	giv[60]|giv|new[64]	_	_
9-10	1537-1546	reduction	abstract[60]|abstract[64]	giv[60]|new[64]	_	_
9-11	1547-1552	under	abstract[60]|abstract[64]	giv[60]|new[64]	_	_
9-12	1553-1557	TSST	abstract[60]|abstract[64]|abstract|abstract[66]	giv[60]|new[64]|giv|new[66]	coref|coref|coref|coref	10-12|11-11[0_66]|10-12|11-11[0_66]
9-13	1558-1564	stress	abstract[60]|abstract[64]|abstract[66]	giv[60]|new[64]|new[66]	_	_
9-14	1565-1569	were	_	_	_	_
9-15	1570-1574	also	_	_	_	_
9-16	1575-1580	found	_	_	_	_
9-17	1581-1583	in	_	_	_	_
9-18	1584-1591	several	abstract[67]	new[67]	coref	23-1[188_67]
9-19	1592-1597	other	abstract[67]	new[67]	_	_
9-20	1598-1607	protocols	abstract[67]	new[67]	_	_
9-21	1608-1609	(	_	_	_	_
9-22	1610-1613	see	_	_	_	_
9-23	1614-1615	)	_	_	_	_
9-24	1616-1617	,	_	_	_	_
9-25	1618-1631	strengthening	_	_	_	_
9-26	1632-1635	the	abstract[68]	new[68]	_	_
9-27	1636-1646	scientific	abstract[68]	new[68]	_	_
9-28	1647-1652	value	abstract[68]	new[68]	_	_
9-29	1653-1655	of	abstract[68]	new[68]	_	_
9-30	1656-1659	our	abstract[68]|person|abstract[70]	new[68]|giv|giv[70]	coref|ana|coref|ana	18-1[139_70]|21-18|18-1[139_70]|21-18
9-31	1660-1668	findings	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
9-32	1669-1670	.	_	_	_	_

#Text=The comparison between ANS responses to olfactory stimulation and to the TSST protocol made it possible to compare Task I and Task II , as well as Task II and Task III responses , and highlighted a much higher contribution to the SNS activation borne by the TSST .
10-1	1671-1674	The	abstract[71]	new[71]	_	_
10-2	1675-1685	comparison	abstract[71]	new[71]	_	_
10-3	1686-1693	between	abstract[71]	new[71]	_	_
10-4	1694-1697	ANS	abstract[71]|place|abstract[73]	new[71]|giv|giv[73]	coref|coref|coref|coref	10-32[83_73]|12-8|10-32[83_73]|12-8
10-5	1698-1707	responses	abstract[71]|abstract[73]	new[71]|giv[73]	_	_
10-6	1708-1710	to	abstract[71]|abstract[73]	new[71]|giv[73]	_	_
10-7	1711-1720	olfactory	abstract[71]|abstract[73]|abstract[74]	new[71]|giv[73]|giv[74]	coref	12-4[95_74]
10-8	1721-1732	stimulation	abstract[71]|abstract[73]|abstract[74]	new[71]|giv[73]|giv[74]	_	_
10-9	1733-1736	and	abstract[71]|abstract[73]	new[71]|giv[73]	_	_
10-10	1737-1739	to	abstract[71]|abstract[73]	new[71]|giv[73]	_	_
10-11	1740-1743	the	abstract[71]|abstract[73]|abstract[76]	new[71]|giv[73]|giv[76]	ana	10-15[0_76]
10-12	1744-1748	TSST	abstract[71]|abstract[73]|abstract|abstract[76]	new[71]|giv[73]|giv|giv[76]	coref	10-47[87_0]
10-13	1749-1757	protocol	abstract[71]|abstract[73]|abstract[76]	new[71]|giv[73]|giv[76]	_	_
10-14	1758-1762	made	_	_	_	_
10-15	1763-1765	it	abstract	giv	coref	14-21[120_0]
10-16	1766-1774	possible	_	_	_	_
10-17	1775-1777	to	_	_	_	_
10-18	1778-1785	compare	_	_	_	_
10-19	1786-1790	Task	abstract|abstract[79]	new|new[79]	coref|coref|coref|coref	10-22[81_0]|14-11[114_79]|10-22[81_0]|14-11[114_79]
10-20	1791-1792	I	abstract[79]|person	new[79]|acc	_	_
10-21	1793-1796	and	abstract[79]	new[79]	_	_
10-22	1797-1801	Task	abstract[79]|abstract[81]	new[79]|giv[81]	coref	10-28[82_81]
10-23	1802-1804	II	abstract[79]|abstract[81]	new[79]|giv[81]	_	_
10-24	1805-1806	,	abstract[79]	new[79]	_	_
10-25	1807-1809	as	abstract[79]	new[79]	_	_
10-26	1810-1814	well	abstract[79]	new[79]	_	_
10-27	1815-1817	as	abstract[79]	new[79]	_	_
10-28	1818-1822	Task	abstract[79]|abstract[82]	new[79]|giv[82]	coref	11-8[90_82]
10-29	1823-1825	II	abstract[79]|abstract[82]	new[79]|giv[82]	_	_
10-30	1826-1829	and	abstract[79]|abstract[82]	new[79]|giv[82]	_	_
10-31	1830-1834	Task	abstract[79]|abstract[82]	new[79]|giv[82]	_	_
10-32	1835-1838	III	abstract[79]|abstract[82]|abstract[83]	new[79]|giv[82]|giv[83]	_	_
10-33	1839-1848	responses	abstract[79]|abstract[82]|abstract[83]	new[79]|giv[82]|giv[83]	_	_
10-34	1849-1850	,	abstract[79]	new[79]	_	_
10-35	1851-1854	and	abstract[79]	new[79]	_	_
10-36	1855-1866	highlighted	abstract[79]	new[79]	_	_
10-37	1867-1868	a	abstract[79]|abstract[84]	new[79]|new[84]	_	_
10-38	1869-1873	much	abstract[79]|abstract[84]	new[79]|new[84]	_	_
10-39	1874-1880	higher	abstract[79]|abstract[84]	new[79]|new[84]	_	_
10-40	1881-1893	contribution	abstract[79]|abstract[84]	new[79]|new[84]	_	_
10-41	1894-1896	to	abstract[79]|abstract[84]	new[79]|new[84]	_	_
10-42	1897-1900	the	abstract[79]|abstract[84]|abstract[86]	new[79]|new[84]|giv[86]	coref	12-8[97_86]
10-43	1901-1904	SNS	abstract[79]|abstract[84]|abstract|abstract[86]	new[79]|new[84]|giv|giv[86]	_	_
10-44	1905-1915	activation	abstract[79]|abstract[84]|abstract[86]	new[79]|new[84]|giv[86]	_	_
10-45	1916-1921	borne	_	_	_	_
10-46	1922-1924	by	_	_	_	_
10-47	1925-1928	the	abstract[87]	giv[87]	coref	11-3[0_87]
10-48	1929-1933	TSST	abstract[87]	giv[87]	_	_
10-49	1934-1935	.	_	_	_	_

#Text=Therefore , TSST was confirmed to represent a powerful psychosocial stress task capable to induce an acute stress response of all main physiologic stress systems .
11-1	1936-1945	Therefore	_	_	_	_
11-2	1946-1947	,	_	_	_	_
11-3	1948-1952	TSST	abstract	giv	coref	13-13
11-4	1953-1956	was	_	_	_	_
11-5	1957-1966	confirmed	_	_	_	_
11-6	1967-1969	to	_	_	_	_
11-7	1970-1979	represent	_	_	_	_
11-8	1980-1981	a	abstract[90]	giv[90]	coref	14-11[113_90]
11-9	1982-1990	powerful	abstract[90]	giv[90]	_	_
11-10	1991-2003	psychosocial	abstract[90]	giv[90]	_	_
11-11	2004-2010	stress	abstract|abstract[90]	giv|giv[90]	coref	11-18
11-12	2011-2015	task	abstract[90]	giv[90]	_	_
11-13	2016-2023	capable	abstract[90]	giv[90]	_	_
11-14	2024-2026	to	abstract[90]	giv[90]	_	_
11-15	2027-2033	induce	abstract[90]	giv[90]	_	_
11-16	2034-2036	an	abstract[90]|abstract[92]	giv[90]|giv[92]	coref	13-4[100_92]
11-17	2037-2042	acute	abstract[90]|abstract[92]	giv[90]|giv[92]	_	_
11-18	2043-2049	stress	abstract[90]|abstract|abstract[92]	giv[90]|giv|giv[92]	coref	11-24
11-19	2050-2058	response	abstract[90]|abstract[92]	giv[90]|giv[92]	_	_
11-20	2059-2061	of	abstract[90]|abstract[92]	giv[90]|giv[92]	_	_
11-21	2062-2065	all	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
11-22	2066-2070	main	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
11-23	2071-2082	physiologic	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
11-24	2083-2089	stress	abstract[90]|abstract[92]|abstract|abstract[94]	giv[90]|giv[92]|giv|new[94]	coref	13-19
11-25	2090-2097	systems	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
11-26	2098-2099	.	_	_	_	_

#Text=In addition , olfactory stimulation also elicited ANS activation ( particularly SNS )
12-1	2100-2102	In	_	_	_	_
12-2	2103-2111	addition	_	_	_	_
12-3	2112-2113	,	_	_	_	_
12-4	2114-2123	olfactory	abstract[95]	giv[95]	coref	25-20[204_95]
12-5	2124-2135	stimulation	abstract[95]	giv[95]	_	_
12-6	2136-2140	also	_	_	_	_
12-7	2141-2149	elicited	_	_	_	_
12-8	2150-2153	ANS	place|abstract[97]	giv|giv[97]	appos|coref|appos|coref	12-11[98_97]|14-18|12-11[98_97]|14-18
12-9	2154-2164	activation	abstract[97]	giv[97]	_	_
12-10	2165-2166	(	_	_	_	_
12-11	2167-2179	particularly	abstract[98]	giv[98]	coref	14-29[121_98]
12-12	2180-2183	SNS	abstract[98]	giv[98]	_	_
12-13	2184-2185	)	_	_	_	_

#Text=The magnitude of this response was significantly smaller than that occurring with TSST , highlighting its usefulness in stress monitoring of subjects unable to undergo complex mathematical stress tests , limited to some particularly controlled experimental settings .
13-1	2186-2189	The	abstract[99]	new[99]	_	_
13-2	2190-2199	magnitude	abstract[99]	new[99]	_	_
13-3	2200-2202	of	abstract[99]	new[99]	_	_
13-4	2203-2207	this	abstract[99]|abstract[100]	new[99]|giv[100]	coref	29-25[238_100]
13-5	2208-2216	response	abstract[99]|abstract[100]	new[99]|giv[100]	_	_
13-6	2217-2220	was	_	_	_	_
13-7	2221-2234	significantly	_	_	_	_
13-8	2235-2242	smaller	_	_	_	_
13-9	2243-2247	than	_	_	_	_
13-10	2248-2252	that	_	_	_	_
13-11	2253-2262	occurring	_	_	_	_
13-12	2263-2267	with	_	_	_	_
13-13	2268-2272	TSST	abstract	giv	ana	13-16
13-14	2273-2274	,	_	_	_	_
13-15	2275-2287	highlighting	_	_	_	_
13-16	2288-2291	its	abstract|abstract[103]	giv|new[103]	coref|coref	15-15|15-15
13-17	2292-2302	usefulness	abstract[103]	new[103]	_	_
13-18	2303-2305	in	abstract[103]	new[103]	_	_
13-19	2306-2312	stress	abstract[103]|abstract|event[105]	new[103]|giv|new[105]	coref|coref	13-28|13-28
13-20	2313-2323	monitoring	abstract[103]|event[105]	new[103]|new[105]	_	_
13-21	2324-2326	of	abstract[103]|event[105]	new[103]|new[105]	_	_
13-22	2327-2335	subjects	abstract[103]|event[105]|abstract[106]	new[103]|new[105]|giv[106]	coref	15-9[0_106]
13-23	2336-2342	unable	abstract[103]|event[105]|abstract[106]	new[103]|new[105]|giv[106]	_	_
13-24	2343-2345	to	abstract[103]|event[105]|abstract[106]	new[103]|new[105]|giv[106]	_	_
13-25	2346-2353	undergo	abstract[103]|event[105]|abstract[106]	new[103]|new[105]|giv[106]	_	_
13-26	2354-2361	complex	abstract[103]|event[105]|abstract[106]|abstract[108]	new[103]|new[105]|giv[106]|giv[108]	_	_
13-27	2362-2374	mathematical	abstract[103]|event[105]|abstract[106]|abstract[108]	new[103]|new[105]|giv[106]|giv[108]	_	_
13-28	2375-2381	stress	abstract[103]|event[105]|abstract[106]|abstract|abstract[108]	new[103]|new[105]|giv[106]|giv|giv[108]	coref	14-24
13-29	2382-2387	tests	abstract[103]|event[105]|abstract[106]|abstract[108]	new[103]|new[105]|giv[106]|giv[108]	_	_
13-30	2388-2389	,	_	_	_	_
13-31	2390-2397	limited	_	_	_	_
13-32	2398-2400	to	_	_	_	_
13-33	2401-2405	some	abstract[109]	new[109]	_	_
13-34	2406-2418	particularly	abstract[109]	new[109]	_	_
13-35	2419-2429	controlled	abstract[109]	new[109]	_	_
13-36	2430-2442	experimental	abstract[109]	new[109]	_	_
13-37	2443-2451	settings	abstract[109]	new[109]	_	_
13-38	2452-2453	.	_	_	_	_

#Text=Interestingly , the trends noticed in the phase transition between Task III and recovery suggest an overall ANS withdrawal after a massive psycho-sensory stress protocol , being that both SNS and PNS activity decreased at this stage .
14-1	2454-2467	Interestingly	_	_	_	_
14-2	2468-2469	,	_	_	_	_
14-3	2470-2473	the	abstract[110]	new[110]	_	_
14-4	2474-2480	trends	abstract[110]	new[110]	_	_
14-5	2481-2488	noticed	_	_	_	_
14-6	2489-2491	in	_	_	_	_
14-7	2492-2495	the	event[112]	new[112]	_	_
14-8	2496-2501	phase	abstract|event[112]	new|new[112]	coref	14-36[124_0]
14-9	2502-2512	transition	event[112]	new[112]	_	_
14-10	2513-2520	between	event[112]	new[112]	_	_
14-11	2521-2525	Task	event[112]|abstract[113]|abstract[114]	new[112]|giv[113]|giv[114]	_	_
14-12	2526-2529	III	event[112]|abstract[113]|abstract[114]	new[112]|giv[113]|giv[114]	_	_
14-13	2530-2533	and	event[112]|abstract[114]	new[112]|giv[114]	_	_
14-14	2534-2542	recovery	event[112]|abstract[114]|event	new[112]|giv[114]|new	coref	24-14
14-15	2543-2550	suggest	_	_	_	_
14-16	2551-2553	an	abstract[117]	giv[117]	_	_
14-17	2554-2561	overall	abstract[117]	giv[117]	_	_
14-18	2562-2565	ANS	place|abstract[117]	giv|giv[117]	coref	21-23
14-19	2566-2576	withdrawal	abstract[117]	giv[117]	_	_
14-20	2577-2582	after	abstract[117]	giv[117]	_	_
14-21	2583-2584	a	abstract[117]|abstract[120]	giv[117]|giv[120]	coref	15-14[128_120]
14-22	2585-2592	massive	abstract[117]|abstract[120]	giv[117]|giv[120]	_	_
14-23	2593-2607	psycho-sensory	abstract[117]|abstract|abstract[120]	giv[117]|new|giv[120]	_	_
14-24	2608-2614	stress	abstract[117]|abstract|abstract[120]	giv[117]|giv|giv[120]	coref	21-34
14-25	2615-2623	protocol	abstract[117]|abstract[120]	giv[117]|giv[120]	_	_
14-26	2624-2625	,	abstract[117]	giv[117]	_	_
14-27	2626-2631	being	abstract[117]	giv[117]	_	_
14-28	2632-2636	that	abstract[117]	giv[117]	_	_
14-29	2637-2641	both	abstract[117]|abstract[121]|abstract[123]	giv[117]|giv[121]|giv[123]	coref|coref	15-18[130_121]|15-18[130_121]
14-30	2642-2645	SNS	abstract[117]|abstract[121]|abstract[123]	giv[117]|giv[121]|giv[123]	_	_
14-31	2646-2649	and	abstract[117]|abstract[123]	giv[117]|giv[123]	_	_
14-32	2650-2653	PNS	abstract[117]|place|abstract[123]	giv[117]|new|giv[123]	coref	15-19
14-33	2654-2662	activity	abstract[117]|abstract[123]	giv[117]|giv[123]	_	_
14-34	2663-2672	decreased	_	_	_	_
14-35	2673-2675	at	_	_	_	_
14-36	2676-2680	this	abstract[124]	giv[124]	coref	15-22[131_124]
14-37	2681-2686	stage	abstract[124]	giv[124]	_	_
14-38	2687-2688	.	_	_	_	_

#Text=Finally , the only significant correlation revealed that subjects who more quickly completing the TSST protocol displayed higher PNS activation in the following phase .
15-1	2689-2696	Finally	_	_	_	_
15-2	2697-2698	,	_	_	_	_
15-3	2699-2702	the	abstract[125]	new[125]	_	_
15-4	2703-2707	only	abstract[125]	new[125]	_	_
15-5	2708-2719	significant	abstract[125]	new[125]	_	_
15-6	2720-2731	correlation	abstract[125]	new[125]	_	_
15-7	2732-2740	revealed	_	_	_	_
15-8	2741-2745	that	_	_	_	_
15-9	2746-2754	subjects	abstract	giv	coref	20-25[154_0]
15-10	2755-2758	who	_	_	_	_
15-11	2759-2763	more	_	_	_	_
15-12	2764-2771	quickly	_	_	_	_
15-13	2772-2782	completing	_	_	_	_
15-14	2783-2786	the	abstract[128]	giv[128]	coref	21-13[168_128]
15-15	2787-2791	TSST	abstract|abstract[128]	giv|giv[128]	_	_
15-16	2792-2800	protocol	abstract[128]	giv[128]	_	_
15-17	2801-2810	displayed	_	_	_	_
15-18	2811-2817	higher	abstract[130]	giv[130]	_	_
15-19	2818-2821	PNS	place|abstract[130]	giv|giv[130]	coref	16-12[134_0]
15-20	2822-2832	activation	abstract[130]	giv[130]	_	_
15-21	2833-2835	in	_	_	_	_
15-22	2836-2839	the	abstract[131]	giv[131]	coref	24-13[198_131]
15-23	2840-2849	following	abstract[131]	giv[131]	_	_
15-24	2850-2855	phase	abstract[131]	giv[131]	_	_
15-25	2856-2857	.	_	_	_	_

#Text=This result could be speculated in terms of sustained hyper-reactivity of the PNS , as a marker of increased selective attention and higher-order behavior and cognition ( e. g. , see ) .
16-1	2858-2862	This	abstract[132]	new[132]	_	_
16-2	2863-2869	result	abstract[132]	new[132]	_	_
16-3	2870-2875	could	_	_	_	_
16-4	2876-2878	be	_	_	_	_
16-5	2879-2889	speculated	_	_	_	_
16-6	2890-2892	in	_	_	_	_
16-7	2893-2898	terms	_	_	_	_
16-8	2899-2901	of	_	_	_	_
16-9	2902-2911	sustained	abstract[133]	new[133]	_	_
16-10	2912-2928	hyper-reactivity	abstract[133]	new[133]	_	_
16-11	2929-2931	of	abstract[133]	new[133]	_	_
16-12	2932-2935	the	abstract[133]|place[134]	new[133]|giv[134]	_	_
16-13	2936-2939	PNS	abstract[133]|place[134]	new[133]|giv[134]	_	_
16-14	2940-2941	,	_	_	_	_
16-15	2942-2944	as	_	_	_	_
16-16	2945-2946	a	_	_	_	_
16-17	2947-2953	marker	_	_	_	_
16-18	2954-2956	of	_	_	_	_
16-19	2957-2966	increased	abstract[135]	new[135]	_	_
16-20	2967-2976	selective	abstract[135]	new[135]	_	_
16-21	2977-2986	attention	abstract[135]	new[135]	_	_
16-22	2987-2990	and	_	_	_	_
16-23	2991-3003	higher-order	abstract[136]	giv[136]	_	_
16-24	3004-3012	behavior	abstract[136]	giv[136]	_	_
16-25	3013-3016	and	_	_	_	_
16-26	3017-3026	cognition	abstract	new	_	_
16-27	3027-3028	(	_	_	_	_
16-28	3029-3031	e.	_	_	_	_
16-29	3032-3034	g.	_	_	_	_
16-30	3035-3036	,	_	_	_	_
16-31	3037-3040	see	_	_	_	_
16-32	3041-3042	)	_	_	_	_
16-33	3043-3044	.	_	_	_	_

#Text=Limitations
17-1	3045-3056	Limitations	abstract	new	coref	18-12[142_0]

#Text=All these findings should be taken into account in light of some limitations .
18-1	3057-3060	All	abstract[139]	giv[139]	_	_
18-2	3061-3066	these	abstract[139]	giv[139]	_	_
18-3	3067-3075	findings	abstract[139]	giv[139]	_	_
18-4	3076-3082	should	_	_	_	_
18-5	3083-3085	be	_	_	_	_
18-6	3086-3091	taken	_	_	_	_
18-7	3092-3096	into	_	_	_	_
18-8	3097-3104	account	abstract[140]	new[140]	coref	26-7[0_140]
18-9	3105-3107	in	abstract[140]	new[140]	_	_
18-10	3108-3113	light	abstract[140]|object[141]	new[140]|new[141]	_	_
18-11	3114-3116	of	abstract[140]|object[141]	new[140]|new[141]	_	_
18-12	3117-3121	some	abstract[140]|object[141]|abstract[142]	new[140]|new[141]|giv[142]	_	_
18-13	3122-3133	limitations	abstract[140]|object[141]|abstract[142]	new[140]|new[141]|giv[142]	_	_
18-14	3134-3135	.	_	_	_	_

#Text=First , the relatively small sample size does not allow drawing considerations based on subgroups ( e. g. , gender- or age-based , etc. ) .
19-1	3136-3141	First	_	_	_	_
19-2	3142-3143	,	_	_	_	_
19-3	3144-3147	the	quantity[144]	new[144]	_	_
19-4	3148-3158	relatively	quantity[144]	new[144]	_	_
19-5	3159-3164	small	quantity[144]	new[144]	_	_
19-6	3165-3171	sample	object|quantity[144]	new|new[144]	_	_
19-7	3172-3176	size	quantity[144]	new[144]	_	_
19-8	3177-3181	does	_	_	_	_
19-9	3182-3185	not	_	_	_	_
19-10	3186-3191	allow	_	_	_	_
19-11	3192-3199	drawing	abstract[145]	new[145]	coref	30-4[242_145]
19-12	3200-3214	considerations	abstract[145]	new[145]	_	_
19-13	3215-3220	based	_	_	_	_
19-14	3221-3223	on	_	_	_	_
19-15	3224-3233	subgroups	abstract	new	appos	19-17[147_0]
19-16	3234-3235	(	_	_	_	_
19-17	3236-3238	e.	abstract[147]	giv[147]	appos	19-20[0_147]
19-18	3239-3241	g.	abstract[147]	giv[147]	_	_
19-19	3242-3243	,	_	_	_	_
19-20	3244-3251	gender-	abstract	giv	_	_
19-21	3252-3254	or	_	_	_	_
19-22	3255-3264	age-based	_	_	_	_
19-23	3265-3266	,	_	_	_	_
19-24	3267-3271	etc.	_	_	_	_
19-25	3272-3273	)	_	_	_	_
19-26	3274-3275	.	_	_	_	_

#Text=This fact did not allow investigating the possible effects of confounding factors , including gender-specific ones ( i. e. , the sexual-hormone influences for female subjects , menstrual cycle phases , etc. ) or variables related to some physical characteristics of the subjects ( i. e. , the body mass index ) , even though none of the volunteers was apparently under- or overweight .
20-1	3276-3280	This	abstract[149]	new[149]	_	_
20-2	3281-3285	fact	abstract[149]	new[149]	_	_
20-3	3286-3289	did	_	_	_	_
20-4	3290-3293	not	_	_	_	_
20-5	3294-3299	allow	_	_	_	_
20-6	3300-3313	investigating	_	_	_	_
20-7	3314-3317	the	abstract[150]	new[150]	coref	25-16[203_150]
20-8	3318-3326	possible	abstract[150]	new[150]	_	_
20-9	3327-3334	effects	abstract[150]	new[150]	_	_
20-10	3335-3337	of	_	_	_	_
20-11	3338-3349	confounding	_	_	_	_
20-12	3350-3357	factors	abstract[151]	new[151]	_	_
20-13	3358-3359	,	abstract[151]	new[151]	_	_
20-14	3360-3369	including	abstract[151]	new[151]	_	_
20-15	3370-3385	gender-specific	abstract[151]|abstract[152]	new[151]|new[152]	_	_
20-16	3386-3390	ones	abstract[151]|abstract[152]	new[151]|new[152]	_	_
20-17	3391-3392	(	_	_	_	_
20-18	3393-3395	i.	_	_	_	_
20-19	3396-3398	e.	_	_	_	_
20-20	3399-3400	,	_	_	_	_
20-21	3401-3404	the	abstract[153]	new[153]	_	_
20-22	3405-3419	sexual-hormone	abstract[153]	new[153]	_	_
20-23	3420-3430	influences	abstract[153]	new[153]	_	_
20-24	3431-3434	for	abstract[153]	new[153]	_	_
20-25	3435-3441	female	abstract[153]|abstract[154]	new[153]|giv[154]	coref	20-42[160_154]
20-26	3442-3450	subjects	abstract[153]|abstract[154]	new[153]|giv[154]	_	_
20-27	3451-3452	,	abstract[153]	new[153]	_	_
20-28	3453-3462	menstrual	abstract[153]|person|abstract[157]	new[153]|new|new[157]	_	_
20-29	3463-3468	cycle	abstract[153]|abstract|abstract[157]	new[153]|new|new[157]	_	_
20-30	3469-3475	phases	abstract[153]|abstract[157]	new[153]|new[157]	_	_
20-31	3476-3477	,	abstract[153]	new[153]	_	_
20-32	3478-3482	etc.	abstract[153]	new[153]	_	_
20-33	3483-3484	)	_	_	_	_
20-34	3485-3487	or	_	_	_	_
20-35	3488-3497	variables	abstract	new	_	_
20-36	3498-3505	related	_	_	_	_
20-37	3506-3508	to	_	_	_	_
20-38	3509-3513	some	abstract[159]	new[159]	_	_
20-39	3514-3522	physical	abstract[159]	new[159]	_	_
20-40	3523-3538	characteristics	abstract[159]	new[159]	_	_
20-41	3539-3541	of	abstract[159]	new[159]	_	_
20-42	3542-3545	the	abstract[159]|abstract[160]	new[159]|giv[160]	_	_
20-43	3546-3554	subjects	abstract[159]|abstract[160]	new[159]|giv[160]	_	_
20-44	3555-3556	(	_	_	_	_
20-45	3557-3559	i.	_	_	_	_
20-46	3560-3562	e.	_	_	_	_
20-47	3563-3564	,	_	_	_	_
20-48	3565-3568	the	abstract[163]	new[163]	coref	28-21[228_163]
20-49	3569-3573	body	object|abstract[163]	new|new[163]	_	_
20-50	3574-3578	mass	quantity|abstract[163]	new|new[163]	_	_
20-51	3579-3584	index	abstract[163]	new[163]	_	_
20-52	3585-3586	)	_	_	_	_
20-53	3587-3588	,	_	_	_	_
20-54	3589-3593	even	_	_	_	_
20-55	3594-3600	though	_	_	_	_
20-56	3601-3605	none	event	new	_	_
20-57	3606-3608	of	_	_	_	_
20-58	3609-3612	the	person[165]	giv[165]	coref	21-37[174_165]
20-59	3613-3623	volunteers	person[165]	giv[165]	_	_
20-60	3624-3627	was	_	_	_	_
20-61	3628-3638	apparently	_	_	_	_
20-62	3639-3645	under-	_	_	_	_
20-63	3646-3648	or	_	_	_	_
20-64	3649-3659	overweight	_	_	_	_
20-65	3660-3661	.	_	_	_	_

#Text=Second , due to the necessity of keeping the overall length of the protocol reasonably low , we did not consider long-term ANS measurements that could be more precise in characterizing the overall stress state of the volunteers .
21-1	3662-3668	Second	_	_	_	_
21-2	3669-3670	,	_	_	_	_
21-3	3671-3674	due	_	_	_	_
21-4	3675-3677	to	_	_	_	_
21-5	3678-3681	the	abstract[166]	new[166]	_	_
21-6	3682-3691	necessity	abstract[166]	new[166]	_	_
21-7	3692-3694	of	_	_	_	_
21-8	3695-3702	keeping	_	_	_	_
21-9	3703-3706	the	quantity[167]	new[167]	_	_
21-10	3707-3714	overall	quantity[167]	new[167]	_	_
21-11	3715-3721	length	quantity[167]	new[167]	_	_
21-12	3722-3724	of	quantity[167]	new[167]	_	_
21-13	3725-3728	the	quantity[167]|abstract[168]	new[167]|giv[168]	_	_
21-14	3729-3737	protocol	quantity[167]|abstract[168]	new[167]|giv[168]	_	_
21-15	3738-3748	reasonably	quantity[167]|abstract[168]	new[167]|giv[168]	_	_
21-16	3749-3752	low	quantity[167]|abstract[168]	new[167]|giv[168]	_	_
21-17	3753-3754	,	_	_	_	_
21-18	3755-3757	we	person	giv	ana	22-8
21-19	3758-3761	did	_	_	_	_
21-20	3762-3765	not	_	_	_	_
21-21	3766-3774	consider	_	_	_	_
21-22	3775-3784	long-term	abstract[171]	new[171]	_	_
21-23	3785-3788	ANS	place|abstract[171]	giv|new[171]	coref	23-25
21-24	3789-3801	measurements	abstract[171]	new[171]	_	_
21-25	3802-3806	that	_	_	_	_
21-26	3807-3812	could	_	_	_	_
21-27	3813-3815	be	_	_	_	_
21-28	3816-3820	more	_	_	_	_
21-29	3821-3828	precise	_	_	_	_
21-30	3829-3831	in	_	_	_	_
21-31	3832-3846	characterizing	_	_	_	_
21-32	3847-3850	the	abstract[173]	new[173]	coref	22-34[185_173]
21-33	3851-3858	overall	abstract[173]	new[173]	_	_
21-34	3859-3865	stress	abstract|abstract[173]	giv|new[173]	coref	23-15[191_0]
21-35	3866-3871	state	abstract[173]	new[173]	_	_
21-36	3872-3874	of	abstract[173]	new[173]	_	_
21-37	3875-3878	the	abstract[173]|person[174]	new[173]|giv[174]	_	_
21-38	3879-3889	volunteers	abstract[173]|person[174]	new[173]|giv[174]	_	_
21-39	3890-3891	.	_	_	_	_

#Text=Third , for the same reason , we decided not to administer stress-related questionnaires , such as Visual Analogue Scale ( VAS ) or State-Trait Anxiety Inventory ( STAI ) , to monitor both state and trait anxiety .
22-1	3892-3897	Third	_	_	_	_
22-2	3898-3899	,	_	_	_	_
22-3	3900-3903	for	_	_	_	_
22-4	3904-3907	the	abstract[175]	new[175]	coref	24-4[195_175]
22-5	3908-3912	same	abstract[175]	new[175]	_	_
22-6	3913-3919	reason	abstract[175]	new[175]	_	_
22-7	3920-3921	,	_	_	_	_
22-8	3922-3924	we	person	giv	ana	24-9
22-9	3925-3932	decided	_	_	_	_
22-10	3933-3936	not	_	_	_	_
22-11	3937-3939	to	_	_	_	_
22-12	3940-3950	administer	_	_	_	_
22-13	3951-3965	stress-related	abstract[177]	new[177]	_	_
22-14	3966-3980	questionnaires	abstract[177]	new[177]	_	_
22-15	3981-3982	,	abstract[177]	new[177]	_	_
22-16	3983-3987	such	abstract[177]	new[177]	_	_
22-17	3988-3990	as	abstract[177]	new[177]	_	_
22-18	3991-3997	Visual	abstract[177]|abstract[178]|object[179]	new[177]|new[178]|new[179]	appos|appos	22-22[0_179]|22-22[0_179]
22-19	3998-4006	Analogue	abstract[177]|abstract[178]|object[179]	new[177]|new[178]|new[179]	_	_
22-20	4007-4012	Scale	abstract[177]|object[179]	new[177]|new[179]	_	_
22-21	4013-4014	(	_	_	_	_
22-22	4015-4018	VAS	object	giv	_	_
22-23	4019-4020	)	_	_	_	_
22-24	4021-4023	or	_	_	_	_
22-25	4024-4035	State-Trait	animal|abstract[183]	new|new[183]	_	_
22-26	4036-4043	Anxiety	abstract|abstract[183]	new|new[183]	coref	22-37[187_0]
22-27	4044-4053	Inventory	abstract[183]	new[183]	_	_
22-28	4054-4055	(	_	_	_	_
22-29	4056-4060	STAI	object	new	_	_
22-30	4061-4062	)	_	_	_	_
22-31	4063-4064	,	_	_	_	_
22-32	4065-4067	to	_	_	_	_
22-33	4068-4075	monitor	_	_	_	_
22-34	4076-4080	both	abstract[185]	giv[185]	_	_
22-35	4081-4086	state	abstract[185]	giv[185]	_	_
22-36	4087-4090	and	_	_	_	_
22-37	4091-4096	trait	abstract|abstract[187]	new|giv[187]	_	_
22-38	4097-4104	anxiety	abstract[187]	giv[187]	_	_
22-39	4105-4106	.	_	_	_	_

#Text=Such protocols can be applied in future studies , allowing assessing possible correlations between the subjective , perceived stress and the variations of the ANS parameters .
23-1	4107-4111	Such	abstract[188]	giv[188]	coref	30-7[243_188]
23-2	4112-4121	protocols	abstract[188]	giv[188]	_	_
23-3	4122-4125	can	_	_	_	_
23-4	4126-4128	be	_	_	_	_
23-5	4129-4136	applied	_	_	_	_
23-6	4137-4139	in	_	_	_	_
23-7	4140-4146	future	abstract[189]	new[189]	coref	26-11[207_189]
23-8	4147-4154	studies	abstract[189]	new[189]	_	_
23-9	4155-4156	,	_	_	_	_
23-10	4157-4165	allowing	_	_	_	_
23-11	4166-4175	assessing	_	_	_	_
23-12	4176-4184	possible	abstract[190]	giv[190]	_	_
23-13	4185-4197	correlations	abstract[190]	giv[190]	_	_
23-14	4198-4205	between	abstract[190]	giv[190]	_	_
23-15	4206-4209	the	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
23-16	4210-4220	subjective	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
23-17	4221-4222	,	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
23-18	4223-4232	perceived	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
23-19	4233-4239	stress	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
23-20	4240-4243	and	abstract[190]	giv[190]	_	_
23-21	4244-4247	the	abstract[190]|abstract[192]	giv[190]|new[192]	coref	27-27[214_192]
23-22	4248-4258	variations	abstract[190]|abstract[192]	giv[190]|new[192]	_	_
23-23	4259-4261	of	abstract[190]|abstract[192]	giv[190]|new[192]	_	_
23-24	4262-4265	the	abstract[190]|abstract[192]|abstract[194]	giv[190]|new[192]|giv[194]	_	_
23-25	4266-4269	ANS	abstract[190]|abstract[192]|place|abstract[194]	giv[190]|new[192]|giv|giv[194]	coref	29-27
23-26	4270-4280	parameters	abstract[190]|abstract[192]|abstract[194]	giv[190]|new[192]|giv[194]	_	_
23-27	4281-4282	.	_	_	_	_

#Text=Fourth , for the reason mentioned above , we decided to keep the recovery phase reasonably short .
24-1	4283-4289	Fourth	_	_	_	_
24-2	4290-4291	,	_	_	_	_
24-3	4292-4295	for	_	_	_	_
24-4	4296-4299	the	abstract[195]	giv[195]	_	_
24-5	4300-4306	reason	abstract[195]	giv[195]	_	_
24-6	4307-4316	mentioned	_	_	_	_
24-7	4317-4322	above	_	_	_	_
24-8	4323-4324	,	_	_	_	_
24-9	4325-4327	we	person	giv	_	_
24-10	4328-4335	decided	_	_	_	_
24-11	4336-4338	to	_	_	_	_
24-12	4339-4343	keep	_	_	_	_
24-13	4344-4347	the	abstract[198]	giv[198]	coref	25-6[200_198]
24-14	4348-4356	recovery	event|abstract[198]	giv|giv[198]	_	_
24-15	4357-4362	phase	abstract[198]	giv[198]	_	_
24-16	4363-4373	reasonably	_	_	_	_
24-17	4374-4379	short	_	_	_	_
24-18	4380-4381	.	_	_	_	_

#Text=With a longer duration of this phase , one could have inferred the duration of the autonomic effects of both cognitive and sensory stimulation .
25-1	4382-4386	With	_	_	_	_
25-2	4387-4388	a	abstract[199]	new[199]	_	_
25-3	4389-4395	longer	abstract[199]	new[199]	_	_
25-4	4396-4404	duration	abstract[199]	new[199]	_	_
25-5	4405-4407	of	abstract[199]	new[199]	_	_
25-6	4408-4412	this	abstract[199]|abstract[200]	new[199]|giv[200]	ana	25-9[0_200]
25-7	4413-4418	phase	abstract[199]|abstract[200]	new[199]|giv[200]	_	_
25-8	4419-4420	,	_	_	_	_
25-9	4421-4424	one	abstract	giv	coref	29-30[239_0]
25-10	4425-4430	could	_	_	_	_
25-11	4431-4435	have	_	_	_	_
25-12	4436-4444	inferred	_	_	_	_
25-13	4445-4448	the	abstract[202]	new[202]	_	_
25-14	4449-4457	duration	abstract[202]	new[202]	_	_
25-15	4458-4460	of	abstract[202]	new[202]	_	_
25-16	4461-4464	the	abstract[202]|abstract[203]	new[202]|giv[203]	_	_
25-17	4465-4474	autonomic	abstract[202]|abstract[203]	new[202]|giv[203]	_	_
25-18	4475-4482	effects	abstract[202]|abstract[203]	new[202]|giv[203]	_	_
25-19	4483-4485	of	abstract[202]|abstract[203]	new[202]|giv[203]	_	_
25-20	4486-4490	both	abstract[202]|abstract[203]|abstract[204]	new[202]|giv[203]|giv[204]	_	_
25-21	4491-4500	cognitive	abstract[202]|abstract[203]|abstract[204]	new[202]|giv[203]|giv[204]	_	_
25-22	4501-4504	and	abstract[202]|abstract[203]|abstract[204]	new[202]|giv[203]|giv[204]	_	_
25-23	4505-4512	sensory	abstract[202]|abstract[203]|abstract[204]	new[202]|giv[203]|giv[204]	_	_
25-24	4513-4524	stimulation	abstract[202]|abstract[203]|abstract[204]	new[202]|giv[203]|giv[204]	_	_
25-25	4525-4526	.	_	_	_	_

#Text=This limitation could be taken into account and solved in future studies .
26-1	4527-4531	This	abstract[205]	new[205]	_	_
26-2	4532-4542	limitation	abstract[205]	new[205]	_	_
26-3	4543-4548	could	_	_	_	_
26-4	4549-4551	be	_	_	_	_
26-5	4552-4557	taken	_	_	_	_
26-6	4558-4562	into	_	_	_	_
26-7	4563-4570	account	abstract	giv	_	_
26-8	4571-4574	and	_	_	_	_
26-9	4575-4581	solved	_	_	_	_
26-10	4582-4584	in	_	_	_	_
26-11	4585-4591	future	abstract[207]	giv[207]	coref	28-1[220_207]
26-12	4592-4599	studies	abstract[207]	giv[207]	_	_
26-13	4600-4601	.	_	_	_	_

#Text=Fifth , the somewhat counterintuitive results retrieved in studying time- versus frequency-domain features were partially explained by the contrasting literature explanation regarding the physiological processes underlying frequency-domain variations , as explained in the signal analysis subsection of the Materials and Methods .
27-1	4602-4607	Fifth	_	_	_	_
27-2	4608-4609	,	_	_	_	_
27-3	4610-4613	the	abstract[208]	giv[208]	_	_
27-4	4614-4622	somewhat	abstract[208]	giv[208]	_	_
27-5	4623-4639	counterintuitive	abstract[208]	giv[208]	_	_
27-6	4640-4647	results	abstract[208]	giv[208]	_	_
27-7	4648-4657	retrieved	_	_	_	_
27-8	4658-4660	in	_	_	_	_
27-9	4661-4669	studying	_	_	_	_
27-10	4670-4675	time-	abstract	new	_	_
27-11	4676-4682	versus	_	_	_	_
27-12	4683-4699	frequency-domain	abstract[210]	giv[210]	coref	28-13[224_210]
27-13	4700-4708	features	abstract[210]	giv[210]	_	_
27-14	4709-4713	were	_	_	_	_
27-15	4714-4723	partially	_	_	_	_
27-16	4724-4733	explained	_	_	_	_
27-17	4734-4736	by	_	_	_	_
27-18	4737-4740	the	abstract[212]	new[212]	_	_
27-19	4741-4752	contrasting	abstract[212]	new[212]	_	_
27-20	4753-4763	literature	abstract|abstract[212]	new|new[212]	_	_
27-21	4764-4775	explanation	abstract[212]	new[212]	_	_
27-22	4776-4785	regarding	_	_	_	_
27-23	4786-4789	the	abstract[213]	new[213]	_	_
27-24	4790-4803	physiological	abstract[213]	new[213]	_	_
27-25	4804-4813	processes	abstract[213]	new[213]	_	_
27-26	4814-4824	underlying	_	_	_	_
27-27	4825-4841	frequency-domain	abstract[214]	giv[214]	_	_
27-28	4842-4852	variations	abstract[214]	giv[214]	_	_
27-29	4853-4854	,	_	_	_	_
27-30	4855-4857	as	_	_	_	_
27-31	4858-4867	explained	_	_	_	_
27-32	4868-4870	in	_	_	_	_
27-33	4871-4874	the	abstract[217]	new[217]	_	_
27-34	4875-4881	signal	abstract|abstract[217]	new|new[217]	_	_
27-35	4882-4890	analysis	abstract|abstract[217]	new|new[217]	_	_
27-36	4891-4901	subsection	abstract[217]	new[217]	_	_
27-37	4902-4904	of	abstract[217]	new[217]	_	_
27-38	4905-4908	the	abstract[217]|substance[218]	new[217]|new[218]	_	_
27-39	4909-4918	Materials	abstract[217]|substance[218]	new[217]|new[218]	_	_
27-40	4919-4922	and	abstract[217]	new[217]	_	_
27-41	4923-4930	Methods	abstract[217]|abstract	new[217]|new	_	_
27-42	4931-4932	.	_	_	_	_

#Text=Further studies conducted on larger samples , and using other time-domains and more robust ECG features , including RMSSD and the Cardiac Vagal Index calculated from the Lorenz plot , could also help in clarifying this point .
28-1	4933-4940	Further	abstract[220]	giv[220]	coref	30-31[249_220]
28-2	4941-4948	studies	abstract[220]	giv[220]	_	_
28-3	4949-4958	conducted	_	_	_	_
28-4	4959-4961	on	_	_	_	_
28-5	4962-4968	larger	object[221]	new[221]	_	_
28-6	4969-4976	samples	object[221]	new[221]	_	_
28-7	4977-4978	,	_	_	_	_
28-8	4979-4982	and	_	_	_	_
28-9	4983-4988	using	_	_	_	_
28-10	4989-4994	other	abstract[222]	new[222]	_	_
28-11	4995-5007	time-domains	abstract[222]	new[222]	_	_
28-12	5008-5011	and	_	_	_	_
28-13	5012-5016	more	abstract[224]	giv[224]	_	_
28-14	5017-5023	robust	abstract[224]	giv[224]	_	_
28-15	5024-5027	ECG	abstract|abstract[224]	new|giv[224]	_	_
28-16	5028-5036	features	abstract[224]	giv[224]	_	_
28-17	5037-5038	,	_	_	_	_
28-18	5039-5048	including	_	_	_	_
28-19	5049-5054	RMSSD	abstract	new	_	_
28-20	5055-5058	and	_	_	_	_
28-21	5059-5062	the	abstract[228]	giv[228]	_	_
28-22	5063-5070	Cardiac	person|abstract[228]	new|giv[228]	_	_
28-23	5071-5076	Vagal	person|abstract[228]	new|giv[228]	_	_
28-24	5077-5082	Index	abstract[228]	giv[228]	_	_
28-25	5083-5093	calculated	_	_	_	_
28-26	5094-5098	from	_	_	_	_
28-27	5099-5102	the	object[230]	new[230]	_	_
28-28	5103-5109	Lorenz	person|object[230]	new|new[230]	_	_
28-29	5110-5114	plot	object[230]	new[230]	_	_
28-30	5115-5116	,	_	_	_	_
28-31	5117-5122	could	_	_	_	_
28-32	5123-5127	also	_	_	_	_
28-33	5128-5132	help	_	_	_	_
28-34	5133-5135	in	_	_	_	_
28-35	5136-5146	clarifying	_	_	_	_
28-36	5147-5151	this	abstract[231]	new[231]	_	_
28-37	5152-5157	point	abstract[231]	new[231]	_	_
28-38	5158-5159	.	_	_	_	_

#Text=Finally , the administration of both pleasant and unpleasant odors would have represented a possible confounding factor if one ’s aim was to control the selective ANS response to one of the two categories .
29-1	5160-5167	Finally	_	_	_	_
29-2	5168-5169	,	_	_	_	_
29-3	5170-5173	the	abstract[232]	new[232]	_	_
29-4	5174-5188	administration	abstract[232]	new[232]	_	_
29-5	5189-5191	of	abstract[232]	new[232]	_	_
29-6	5192-5196	both	abstract[232]|abstract[233]	new[232]|new[233]	coref	30-17[0_233]
29-7	5197-5205	pleasant	abstract[232]|abstract[233]	new[232]|new[233]	_	_
29-8	5206-5209	and	abstract[232]|abstract[233]	new[232]|new[233]	_	_
29-9	5210-5220	unpleasant	abstract[232]|abstract[233]	new[232]|new[233]	_	_
29-10	5221-5226	odors	abstract[232]|abstract[233]	new[232]|new[233]	_	_
29-11	5227-5232	would	_	_	_	_
29-12	5233-5237	have	_	_	_	_
29-13	5238-5249	represented	_	_	_	_
29-14	5250-5251	a	abstract[234]	new[234]	_	_
29-15	5252-5260	possible	abstract[234]	new[234]	_	_
29-16	5261-5272	confounding	abstract[234]	new[234]	_	_
29-17	5273-5279	factor	abstract[234]	new[234]	_	_
29-18	5280-5282	if	_	_	_	_
29-19	5283-5286	one	person[235]|abstract[236]	new[235]|new[236]	_	_
29-20	5287-5289	’s	person[235]|abstract[236]	new[235]|new[236]	_	_
29-21	5290-5293	aim	abstract[236]	new[236]	_	_
29-22	5294-5297	was	_	_	_	_
29-23	5298-5300	to	_	_	_	_
29-24	5301-5308	control	_	_	_	_
29-25	5309-5312	the	abstract[238]	giv[238]	_	_
29-26	5313-5322	selective	abstract[238]	giv[238]	_	_
29-27	5323-5326	ANS	place|abstract[238]	giv|giv[238]	_	_
29-28	5327-5335	response	abstract[238]	giv[238]	_	_
29-29	5336-5338	to	_	_	_	_
29-30	5339-5342	one	abstract[239]	giv[239]	_	_
29-31	5343-5345	of	abstract[239]	giv[239]	_	_
29-32	5346-5349	the	abstract[239]|abstract[240]	giv[239]|new[240]	_	_
29-33	5350-5353	two	abstract[239]|abstract[240]	giv[239]|new[240]	_	_
29-34	5354-5364	categories	abstract[239]|abstract[240]	giv[239]|new[240]	_	_
29-35	5365-5366	.	_	_	_	_

#Text=In light of such considerations , future protocols could be structured starting from the selection of odors based on their hedonic tone , even referring to pleasantness data reported in previously published studies .
30-1	5367-5369	In	_	_	_	_
30-2	5370-5375	light	abstract[241]	new[241]	_	_
30-3	5376-5378	of	abstract[241]	new[241]	_	_
30-4	5379-5383	such	abstract[241]|abstract[242]	new[241]|giv[242]	_	_
30-5	5384-5398	considerations	abstract[241]|abstract[242]	new[241]|giv[242]	_	_
30-6	5399-5400	,	_	_	_	_
30-7	5401-5407	future	abstract[243]	giv[243]	_	_
30-8	5408-5417	protocols	abstract[243]	giv[243]	_	_
30-9	5418-5423	could	_	_	_	_
30-10	5424-5426	be	_	_	_	_
30-11	5427-5437	structured	_	_	_	_
30-12	5438-5446	starting	_	_	_	_
30-13	5447-5451	from	_	_	_	_
30-14	5452-5455	the	abstract[244]	new[244]	_	_
30-15	5456-5465	selection	abstract[244]	new[244]	_	_
30-16	5466-5468	of	abstract[244]	new[244]	_	_
30-17	5469-5474	odors	abstract[244]|abstract	new[244]|giv	ana	30-20
30-18	5475-5480	based	_	_	_	_
30-19	5481-5483	on	_	_	_	_
30-20	5484-5489	their	abstract|abstract[247]	giv|new[247]	_	_
30-21	5490-5497	hedonic	abstract[247]	new[247]	_	_
30-22	5498-5502	tone	abstract[247]	new[247]	_	_
30-23	5503-5504	,	_	_	_	_
30-24	5505-5509	even	_	_	_	_
30-25	5510-5519	referring	_	_	_	_
30-26	5520-5522	to	_	_	_	_
30-27	5523-5535	pleasantness	abstract[248]	new[248]	_	_
30-28	5536-5540	data	abstract[248]	new[248]	_	_
30-29	5541-5549	reported	_	_	_	_
30-30	5550-5552	in	_	_	_	_
30-31	5553-5563	previously	abstract[249]	giv[249]	_	_
30-32	5564-5573	published	abstract[249]	giv[249]	_	_
30-33	5574-5581	studies	abstract[249]	giv[249]	_	_
30-34	5582-5583	.	_	_	_	_
